A surprisingly long list of autoimmune diseases can affect the brain, ranging from well-known conditions like multiple sclerosis to rarer and frequently misdiagnosed disorders like anti-NMDA receptor encephalitis. Some of these diseases target the brain directly, with antibodies attacking specific brain proteins, while others are systemic conditions whose immune activity spills into the central nervous system as a secondary complication. The mechanisms vary, from stripping insulation off nerve fibers to inflaming blood vessels deep inside the brain, but a shared feature is that a dysfunctional immune system treats healthy brain tissue as foreign.
Multiple Sclerosis
Multiple sclerosis is the most common autoimmune demyelinating disease of the central nervous system. The immune system attacks myelin, the protective sheath wrapped around nerve fibers, leading to communication breakdowns between the brain and the rest of the body.1PubMed Central. Myelin recovery in multiple sclerosis: the challenge of remyelination Symptoms depend on where the damage occurs: vision problems if the optic nerve is hit, numbness or weakness if the spinal cord is involved, and cognitive fog or fatigue when lesions develop in the brain itself. Over time, chronic loss of myelin can lead to permanent axonal damage, which accounts for the progressive disability many patients experience.
Early in the disease, massive numbers of immune cells cross the blood-brain barrier after cell-adhesion molecules on that barrier become activated. In later stages, breakdown of the barrier around the brain’s outer layer (the cortex) contributes to gray-matter shrinkage, which correlates with cognitive decline.2PubMed Central. Blood-Brain Barrier Disruption in Neuroimmunological Disease MS can follow a relapsing-remitting pattern, where symptoms flare and then partly or fully resolve, or a progressive course, where disability accumulates steadily. Multiple types of immune cells are involved, which is why modern MS therapies aim to reset several components of the immune system at once rather than targeting a single pathway.1PubMed Central. Myelin recovery in multiple sclerosis: the challenge of remyelination
Neuromyelitis Optica Spectrum Disorder
Neuromyelitis optica spectrum disorder (NMOSD) was once thought to be a variant of MS, but it turns out to have a completely different mechanism. Most patients carry antibodies that target aquaporin-4 (AQP4), a water-channel protein found on astrocytes, which are support cells throughout the brain and spinal cord.3PubMed Central. Aquaporin 4 and neuromyelitis optica When these antibodies bind to AQP4, they trigger inflammation that destroys astrocytes and the surrounding tissue, producing severe attacks of optic neuritis (vision loss) and transverse myelitis (spinal cord inflammation).
The disease process depends on those circulating antibodies getting past the blood-brain barrier to reach AQP4 on astrocyte surfaces.4PubMed. Blood-brain barrier dysfunction in immuno-mediated neurological diseases Recent research has identified a second type of antibody, directed against glucose-regulated protein (GRP), that appears to damage the blood-brain barrier itself, essentially opening the gate for the AQP4 antibodies to enter.2PubMed Central. Blood-Brain Barrier Disruption in Neuroimmunological Disease Lab studies show that when AQP4 antibodies bind to astrocytes under normal body-temperature conditions, they cause the water channel to be pulled off the cell surface, reducing the cell’s ability to regulate water flow, a mechanism that helps explain the tissue swelling and damage seen in acute attacks.5PubMed. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane NMOSD attacks tend to be more severe than MS relapses, and the distinction matters because some MS drugs can worsen NMOSD.
MOG Antibody-Associated Disease
MOGAD is a more recently recognized condition caused by antibodies targeting myelin oligodendrocyte glycoprotein (MOG), a protein on the outermost surface of myelin. It can look like MS or NMOSD on a brain scan, but it has distinct immune pathology and often a different prognosis.6PubMed Central. Myelin Oligodendrocyte glycoprotein antibody-associated disease: Current insights into the disease pathophysiology, diagnosis and management MOGAD can cause optic neuritis, transverse myelitis, acute disseminated encephalomyelitis (ADEM, a widespread brain inflammation), brainstem syndromes, and cortical encephalitis.7PubMed. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
Children and adults are both affected, though they tend to present differently. In children, ADEM is one of the more common presentations, while adults more frequently develop optic neuritis.8PubMed. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Practical recommendations for diagnosis and management MOGAD can follow a single-attack course that never returns or a relapsing pattern. Accurate diagnosis requires a specific blood test (a cell-based assay for MOG antibodies), because standard MRI findings alone can be misleading. Getting the diagnosis right matters: the treatment strategies and long-term monitoring differ from MS and NMOSD.
Autoimmune Encephalitis
Autoimmune encephalitis (AE) is a group of conditions in which antibodies attack proteins on the surface of brain cells, causing inflammation that produces a dramatic and often frightening mix of neurological and psychiatric symptoms. The best-studied type is anti-NMDA receptor encephalitis, in which antibodies target NMDA-type glutamate receptors, which are critical for learning, memory, and behavior.9PubMed Central. Anti-NMDA Receptor Encephalitis in Psychiatry
The disease typically progresses in stages. Early on, patients develop psychiatric symptoms that can look a lot like a primary mental illness: paranoia, hallucinations, agitation, or sudden personality changes. If untreated, the disease advances to seizures, movement abnormalities, and eventually reduced consciousness. The staged deterioration happens because the antibodies progressively strip NMDA receptors from the surface of neurons, reducing their function in a stepwise fashion.10Neurotherapeutics. Autoimmune Encephalitis: NMDA Receptor Encephalitis as an Example of Translational Neuroscience Because early symptoms mimic psychiatric illness, patients are sometimes initially admitted to psychiatric units before the underlying autoimmune cause is identified.
Other forms of autoimmune encephalitis target different receptors. Antibodies against LGI1 or CASPR2 cause a condition called limbic encephalitis, which predominantly affects memory. In a review of nearly 470 patients with these antibodies, about 3% had retrograde amnesia (loss of old memories), and the majority of those patients showed only partial cognitive recovery over time.11PubMed Central. Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review This underscores a frustrating reality: even when the immune attack is brought under control, the brain does not always bounce back completely.
When Systemic Autoimmune Diseases Reach the Brain
Several autoimmune diseases that primarily affect other organs can also produce serious brain involvement. These cases are tricky because the neurological symptoms may appear before the systemic disease is recognized, or they may emerge unexpectedly during a disease flare.
Systemic lupus erythematosus (SLE) is the classic example. When lupus affects the nervous system, it is called neuropsychiatric SLE (NPSLE), and it involves both inflammatory and vascular mechanisms. Patients can experience seizures, psychosis, cognitive dysfunction, headaches, or stroke-like episodes. NPSLE is associated with significant morbidity and mortality.12PubMed Central. Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges Blood-brain barrier dysfunction plays a central role, just as it does in MS and NMOSD.4PubMed. Blood-brain barrier dysfunction in immuno-mediated neurological diseases
Sjögren’s syndrome, best known for causing dry eyes and dry mouth, can also involve the central nervous system. Brain MRI in affected patients sometimes reveals extensive white-matter abnormalities or signs of cerebral vasculitis, an inflammation of the blood vessels in the brain.13RMD Open. Epidemiology of neurological manifestations in Sjögren’s syndrome: data from the French ASSESS Cohort Imaging in some cases shows diffuse irregularities in the brain’s arteries and enhancement of vessel walls, pointing to an inflammatory vascular mechanism.14PubMed. Primary Sjogren syndrome with suspected central nervous system inflammatory involvement
Behçet’s disease, a condition that causes painful ulcers and inflammation of blood vessels throughout the body, can produce what is called neuro-Behçet’s disease when it affects the brain. Brain lesions tend to appear in the brainstem and deep brain structures, often associated with vascular clotting. On MRI, acute lesions show up as bright spots that enhance with contrast, commonly in the range of 4 to 10 mm.15PubMed Central. Neuro-Behçet’s syndrome: Case report and literature review The brainstem and the region connecting the thalamus to the internal capsule are particularly vulnerable.16Imaging. Extending brainstem and capsule-thalamic lesions in a patient with parenchymal neuro-Behçet disease
Hashimoto’s Encephalopathy
One of the more puzzling entries on this list is steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT), more commonly known as Hashimoto’s encephalopathy. It occurs in patients with high levels of anti-thyroid antibodies and causes a spectrum of neuropsychiatric symptoms: confusion, seizures, psychosis, dementia-like cognitive decline, and stroke-like episodes.17Neurosciences. Steroid responsive encephalopathy associated with autoimmune thyroiditis presenting with late onset depression The hallmark is that these symptoms improve dramatically with steroid treatment, which is the feature that confirms the diagnosis after other causes are excluded.
SREAT is rare, but the real concern is that it often gets misdiagnosed as a primary psychiatric illness or as unexplained epilepsy, because conventional workups (routine blood tests, standard brain imaging) frequently come back normal or nonspecific.18Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis: Case Report – Significance of History, Suspicion, and Imaging. Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis: Case Report – Significance of History, Suspicion, and Imaging Elevated anti-thyroid antibodies are the key laboratory finding, and recognizing them as relevant to brain symptoms, rather than dismissing them as unrelated thyroid markers, can be the difference between a patient languishing with treatment-resistant “psychiatric illness” and one who recovers fully with steroids.19PubMed Central. Steroid-Responsive Encephalopathy Associated With Autoimmune Thyroiditis Masquerading Sepsis
Paraneoplastic Syndromes and Cerebellar Autoimmunity
Sometimes the immune system attacks the brain as a side effect of fighting cancer. In paraneoplastic neurological syndromes, a tumor elsewhere in the body expresses proteins that closely resemble proteins found on neurons. The immune system mounts a response against the tumor but inadvertently targets the brain as well. Animal research has shown that T cells specific to a paraneoplastic protein (PNMA1) can cause encephalomyelitis when transferred to healthy animals, confirming that the brain damage is genuinely autoimmune and not just a direct effect of cancer spreading.20PubMed. Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat Paraneoplastic syndromes can mimic many other neurological conditions, from limbic encephalitis to progressive cerebellar degeneration, and finding the underlying cancer is critical because treating the tumor is often the most effective way to halt the neurological decline.
The cerebellum, which coordinates movement and balance, is a frequent autoimmune target in its own right. Autoimmune cerebellar ataxia involves antibodies against Purkinje cells, the large output neurons of the cerebellum. Several distinct autoantibodies have been identified, each targeting different proteins in the cytoplasm or dendrites of these cells.21PubMed Central. Autoimmune cerebellar ataxia associated with anti-Purkinje cells antibodies: the next frontier of neuroimmunology Patients develop progressive unsteadiness, slurred speech, and difficulty with fine motor tasks. A particularly interesting form is gluten ataxia, in which antibodies against tissue transglutaminase (anti-TG2 and anti-TG6) cross-react with neurons. Injecting these antibodies into the brains of mice causes ataxia, and the antibodies preferentially bind to the enzyme when it is in its active state, disrupting normal cellular function.22Journal of Movement Disorders. Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms For some patients, a strict gluten-free diet can slow or stabilize the neurological damage.
PANS and PANDAS in Children
In children, a distinct form of brain autoimmunity can emerge suddenly after an infection, most often streptococcal (strep throat). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and the broader category of pediatric acute-onset neuropsychiatric syndrome (PANS) involve a dramatic, overnight onset of obsessive-compulsive behaviors, tics, or severely restricted eating. The proposed mechanism involves immune-mediated inflammation targeting the basal ganglia, deep brain structures involved in movement and habit formation.23PubMed Central. Persistence of Basal Ganglia Dysfunction in PANS/PANDAS: Review of the Evidence
PANS/PANDAS remains somewhat controversial in mainstream neurology, partly because the evidence for the specific autoimmune mechanism is still being built. But the clinical observation is hard to dismiss: a child who was behaving normally one day wakes up the next with severe OCD symptoms or tics, often in the wake of an infection. When the immune component is addressed through antibiotics, anti-inflammatory treatment, or immunotherapy, many children improve. The concept of infection-triggered brain autoimmunity also appears in adults; one case report documented a patient with West Nile Virus who developed autoimmune encephalitis with anti-glycine receptor antibodies, with analysis suggesting molecular mimicry between viral proteins and the receptor.24PubMed. West Nile Virus infection triggering autoimmune encephalitis: Pathophysiological and therapeutic implications
Long-Term Cognitive Outcomes
One question that patients and families ask early is whether recovery from autoimmune brain disease is ever truly complete. The honest answer is that outcomes vary widely, but lingering cognitive problems are common even after the acute immune attack is controlled. In a cohort of patients with various forms of autoimmune encephalitis, about half had persistent cognitive impairment at their most recent follow-up.25PubMed. Long-Term Cognitive Outcomes in Patients with Autoimmune Encephalitis Memory loss was the most frequent residual symptom, affecting roughly half of patients, followed by problems with executive function and attention.26Journal of Neurology, Neurosurgery & Psychiatry. Autoimmune encephalitis: recovery, residual symptoms and predictors of long-term sequelae
Even for anti-NMDA receptor encephalitis, which is considered one of the more treatable forms, the news is sobering. Among patients followed for more than three years, about a third still had measurable impairment in at least one cognitive area, and roughly two-thirds scored below average, despite the majority being rated as having a “favorable” functional outcome on standard clinical scales.27PubMed Central. Long-Term Cognitive, Functional, and Patient-Reported Outcomes in Patients With Anti-NMDAR Encephalitis In other words, a patient may look fine by the usual clinical yardstick (walking, talking, independent in daily life) while still struggling with memory or language in ways that affect work and relationships.
Two factors consistently predict worse long-term outcomes. Delayed immunotherapy, particularly waiting twelve weeks or more from symptom onset, dramatically increases the odds of developing dementia after autoimmune encephalitis. Conversely, having antibodies directed at cell-surface targets (as opposed to intracellular targets) and receiving prolonged immunotherapy for at least two years are both associated with a lower risk of dementia.26Journal of Neurology, Neurosurgery & Psychiatry. Autoimmune encephalitis: recovery, residual symptoms and predictors of long-term sequelae The takeaway for patients is that speed of diagnosis and treatment duration both matter enormously.
Treatment Approaches
Treatment for autoimmune brain diseases generally follows a tiered approach. First-line therapy usually involves high-dose corticosteroids, intravenous immunoglobulin, or plasma exchange (PLEX), all aimed at dampening the immune response quickly. In autoimmune encephalitis, about three-quarters of patients respond to plasma exchange, which physically removes circulating antibodies from the blood. Response rates are higher when the antibodies target proteins on the cell surface (around 83% in one study) and lower when they target proteins inside cells.28PubMed Central. The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative Review
When first-line treatments fail, second-line options include rituximab (which depletes B cells) or cyclophosphamide (a potent immune suppressant). For MS specifically, a growing number of disease-modifying therapies target different immune pathways, from blocking immune-cell migration across the blood-brain barrier to selectively depleting the immune cells most responsible for damage. Treatment choice depends heavily on the specific diagnosis: a drug that works beautifully for MS can be dangerous in NMOSD, and MOGAD has its own emerging treatment protocols. This is why accurate diagnosis, including antibody testing, matters so much in this field.
Why Women Are Disproportionately Affected
Women carry up to a fourfold higher risk of autoimmune disease compared to men.29PubMed Central. Why women have more autoimmune diseases than men: An evolutionary perspective This disparity holds for many of the brain-targeting conditions discussed here. MS, for instance, affects roughly two to three women for every man. Anti-NMDA receptor encephalitis is also more common in young women. The reasons are still debated, but the leading candidates include the effects of sex hormones like estrogen on immune regulation, the presence of two X chromosomes (the X chromosome carries many immune-related genes, and having two copies may amplify immune reactivity), and differences in the gut microbiome between men and women. None of these explanations alone accounts for the full gap, and the reality is probably a combination of all of them interacting in ways researchers are still untangling.
The Gut-Brain Axis Connection
A growing area of research examines how the gut microbiome influences autoimmune brain diseases. The general idea is that the trillions of bacteria living in your intestines communicate with the brain through immune signaling, nerve pathways, and molecules the bacteria themselves produce. Disruptions in the gut’s microbial balance have been linked to a range of neurological conditions, suggesting that the gut and the brain are in constant dialogue and that an unhealthy gut environment might push the immune system toward attacking the nervous system.30PubMed Central. The Gut-Brain Axis in Autoimmune Diseases: Emerging Insights and Therapeutic Implications Gut bacteria regulate the production of neurotransmitters that modulate both local and brain-level immune responses, and when that signaling goes awry, it could promote the kind of neuroinflammation seen in autoimmune brain disorders.31Archives of Medical Reports. The Role of Gut-Derived Neurotransmitters in the Pathogenesis of Autoimmune Neurological Disorders This is still early-stage science, and no one should treat autoimmune encephalitis with probiotics. But it signals where the field is heading and partly explains why diet, infections, and general immune health all seem to influence who develops these conditions and how severe they become.